Rapid Antigen Test for Novel Corona Virus - India CDSCO Medical Device Registration
Rapid Antigen Test for Novel Corona Virus is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000053_3cb38ebdb82e1623e9d8ea90cec2ee12_e6959bffc93230d6ef2e0531361f278a. This device is marketed under the brand name nCOVID-19. The license holder is Dia Sure Immunodiagnostic LLP, and it is classified as Device Class Class C. The approving authority is CDSCO -North Zone, Ghaziabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Brand Name
nCOVID-19
License Holder
Dia Sure Immunodiagnostic LLPDevice Class
Approving Authority
CDSCO -North Zone, Ghaziabad
Product Information
DSI Covid-19 Ag Rapid Test is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in nasopharyngeal swab, using the rapid immuno- chromatographic method.
Chikungunya IgG/IgM Rapid test
Urine Strips
Brucella Ab Rapid Test
Brand: IgG and IgM
Scrub Typhus IgG/IgM Rapid test
Typhoid IgG/IgM Rapid test
Leishmania Ab Rapid Test
HEV IgM Rapid test
Bovine Pregnancy Rapid Test
Brand: IgG and IgM
Bovine Pregnancy Rapid Test
Brand: IgG and IgM
Viral Transport Medium Kit
Brand: DSI Molecular Transport Media